New Hep C treatment on PBS welcome - but still more to do

The Pharmaceutical Benefits Scheme (PBS) listing of Viekira Pak® and Viekira Pak-RBV® from 1 May is a very welcome addition to the highly effective new generation treatment options for people living with hepatitis C.

This good news is tempered by the fact that some people living with less common hepatitis C genotypes are still desperately waiting for new treatments to become available without the terrible side-effects of the older medicine.

Read More